What is Liver Disease?
 

The liver is your body's largest internal organ, responsible for filtering toxins from your blood, processing nutrients, regulating blood clotting, and regulating metabolism. Liver disease is an general term for any condition that damages the liver and impairs its ability to function.

Chronic liver injury can cause progressive scarring over time. The exact progression depends on the underlying liver disease. In steatotic liver disease, progression may occur from excess liver fat (steatosis) → inflammation and liver-cell injury (steatohepatitis) → fibrosis → cirrhosis. Other liver diseases may cause inflammation and fibrosis without first causing fatty liver.

Common Types

 

• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Previously called non-alcoholic fatty liver disease (NAFLD), closely linked to obesity, type 2 diabetes, high cholesterol, and metabolic syndrome. In steatotic liver disease, progression may occur from excess liver fat (steatosis) → inflammation and liver-cell injury (steatohepatitis) → fibrosis → cirrhosis.
   

• Alcohol-Related Liver Disease: Resulting from chronic, heavy alcohol consumption over many years.
   

• Viral Hepatitis: Chronic infections from blood-borne or sexually transmitted viruses, primarily Hepatitis B and Hepatitis C.
   

• Autoimmune Liver Conditions: Diseases where the body's immune system mistakenly attacks liver cells or bile ducts (such as Autoimmune Hepatitis, Primary Biliary Cholangitis, or Primary Sclerosing Cholangitis).
   

• Genetic & Metabolic Disorders: Conditions like hemochromatosis (iron overload) or Wilson's disease (copper accumulation).
   

• Medications & Toxins: Long-term exposure to certain toxins or drug-induced liver injury (such as chronic high-dose acetaminophen overuse or specific prescription medications).

Warning Signs & Common Symptoms
 

• General Symptoms: fatigue, generalized weakness, loss of appetite, and unintended weight loss.

• Abdominal Changes: nausea, pain in the upper right side of the abdomen, and abdominal swelling (ascites).

• Jaundice: A yellowing of the skin and the whites of the eyes caused by a buildup of bilirubin.

• Skin & Circulatory Changes: itchy skin (pruritus) and visible small spider-like blood vessels on the skin (spider angiomas). Excessive bleeding or clotting.

• Urine & Stool Changes: dark, tea-colored urine and pale, clay-colored stools.

• Neurologic Signs: confusion, trouble concentrating, memory loss, or hand tremors caused by ammonia buildup affecting the brain.

• Varices within the digestive system which can rupture and cause severe bleeding

Diagnostics
 

• Liver-Related Tests: ALT, AST, ALP, total bilirubin, albumin, and a complete blood count (CBC).

• FIB-4 Index (Fibrosis-4 Score): A widely used first-line screening formula using age, AST, ALT, and platelet count to calculate the probability of advanced scarring.

• ELF (Enhanced Liver Fibrosis) Score: A specialized blood panel measuring three direct biomarkers (Hyaluronic Acid, PIIINP, and TIMP-1) to evaluate extracellular matrix turnover and stage fibrosis risk.

• FibroScan (Transient Elastography): A specialized, non-invasive ultrasound test that estimates liver stiffness and fat content to grade scarring without a biopsy.

• Abdominal Ultrasound, CT, or MRI: To visualize liver structure, fatty changes, or signs of cirrhosis.​
   

Management & Treatment Strategies
 

• Lifestyle & Dietary Modifications:
   

  • Alcohol abstinence for alcohol-associated liver disease

  • Weight Management & Metabolic Control: Adopting a heart-healthy, low-sugar diet and engaging in regular exercise to reverse fatty liver disease (MASLD) and manage diabetes and cholesterol.

  • Vaccinations: Staying up-to-date on Hepatitis A and Hepatitis B vaccines to protect remaining liver function from secondary viral infections.
     

• Pharmacotherapy:
   

  • Antiviral medications for Hepatitis B and C.

  • Corticosteroids or immunosuppressants for autoimmune forms of hepatitis

  • MASH-Specific Treatment: Resmetirom and semaglutide are FDA-approved treatment options for certain adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate-to-advanced fibrosis (F2–F3) without cirrhosis.

  • Diuretics or nonselective beta blockers for portal hypertension and its complications

  • Lactulose and rifaximin- For excess ammonia buildup causing hepatic encephalopathy

  • Ursodiol- A naturally occurring bile acid used for cholestatic liver diseases (like primary biliary cholangitis) to help protect bile ducts and improve bile flow out of the liver.
     

• Monitoring & Complication Prevention:
   

  • Regular monitoring via blood tests and imaging.

  • Liver Cancer Surveillance: Patients with cirrhosis—and certain patients with chronic hepatitis B even without cirrhosis—generally undergo liver cancer surveillance every 6 months with liver ultrasound and AFP blood testing

                                                         
                                                                               References & Guidelines
 

• American Association for the Study of Liver Diseases (AASLD)

• American College of Gastroenterology (ACG)

• Centers for Disease Control and Prevention (CDC)

• U.S. Food and Drug Administration (FDA)